DKF-313

· Dongkook Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DKF-313, covering 2023-09-21 to 2023-09-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia [Phase 3]